NEW YORK (GenomeWeb) – Linkage Biosciences today announced that it has received CE marking for the LinkSeq Human Leukocyte Antigen test. 

The real-time PCR-based test covers all classical HLA genes and more than 12,000 alleles, and is now available in Europefor in vitro diagnostic applications for solid organ and stem cell transplantation, the South San Francisco-based firm said. 

The CE mark was certified by LNE/GMED. Also, Linkage's quality management system was ISO 13485 certified for the design, development, manufacture, and distribution of LinkSeq products. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.